RAB27A and neoplasm: The enhanced infiltration of CD8α+ T cells into the tumor microenvironment in Rab27a/b-deficient mice does not mitigate tumor progression or increase animal survival relative to tumor-bearing controls (WT and dHET; Fig. 2B).